Clinical Trial Update: Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the immunogenicity of a single Boostrix dose in infants prior to primary pertussis vaccination when administered to pregnant wom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria-Tetanus-Acellular Pertussis | Phase 4 | Status: TERMINATED